Literature DB >> 21841137

Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength.

Aran F Labrijn1, Theo Rispens, Joyce Meesters, Rebecca J Rose, Tamara H den Bleker, Stefan Loverix, Ewald T J van den Bremer, Joost Neijssen, Tom Vink, Ignace Lasters, Rob C Aalberse, Albert J R Heck, Jan G J van de Winkel, Janine Schuurman, Paul W H I Parren.   

Abstract

A distinctive feature of human IgG4 is its ability to recombine half molecules (H chain and attached L chain) through a dynamic process termed Fab-arm exchange, which results in bispecific Abs. It is becoming evident that the process of Fab-arm exchange is conserved in several mammalian species, and thereby represents a mechanism that impacts humoral immunity more generally than previously thought. In humans, Fab-arm exchange has been attributed to the IgG4 core-hinge sequence (226-CPSCP-230) in combination with unknown determinants in the third constant H chain domain (CH3). In this study, we investigated the role of the CH3 domain in the mechanism of Fab-arm exchange, and thus identified amino acid position 409 as the critical CH3 determinant in human IgG, with R409 resulting in exchange and K409 resulting in stable IgG. Interestingly, studies with IgG from various species showed that Fab-arm exchange could not be assigned to a common CH3 domain amino acid motif. Accordingly, in rhesus monkeys (Macaca mulatta), aa 405 was identified as the CH3 determinant responsible (in combination with 226-CPACP-230). Using native mass spectrometry, we demonstrated that the ability to exchange Fab-arms correlated with the CH3-CH3 dissociation constant. Species-specific adaptations in the CH3 domain thus enable Fab-arm exchange by affecting the inter-CH3 domain interaction strength. The redistribution of Ag-binding domains between molecules may constitute a general immunological and evolutionary advantage. The current insights impact our view of humoral immunity and should furthermore be considered in the design and evaluation of Ab-based studies and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841137     DOI: 10.4049/jimmunol.1003336

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  From Rhesus macaque to human: structural evolutionary pathways for immunoglobulin G subclasses.

Authors:  William David Tolbert; Ganesh Prasad Subedi; Neelakshi Gohain; George Kenneth Lewis; Kashyap Rajesh Patel; Adam Wesley Barb; Marzena Pazgier
Journal:  MAbs       Date:  2019-04-02       Impact factor: 5.857

2.  Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Authors:  Shirley J Peters; C Mark Smales; Alistair J Henry; Paul E Stephens; Shauna West; David P Humphreys
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

3.  The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors:  John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

4.  Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.

Authors:  Aran F Labrijn; Joyce I Meesters; Bart E C G de Goeij; Ewald T J van den Bremer; Joost Neijssen; Muriel D van Kampen; Kristin Strumane; Sandra Verploegen; Amitava Kundu; Michael J Gramer; Patrick H C van Berkel; Jan G J van de Winkel; Janine Schuurman; Paul W H I Parren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

5.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

6.  Controlled Fab-arm exchange for the generation of stable bispecific IgG1.

Authors:  Aran F Labrijn; Joyce I Meesters; Patrick Priem; Rob N de Jong; Ewald T J van den Bremer; Muriel D van Kampen; Arnout F Gerritsen; Janine Schuurman; Paul W H I Parren
Journal:  Nat Protoc       Date:  2014-09-25       Impact factor: 13.491

7.  L445P mutation on heavy chain stabilizes IgG4 under acidic conditions.

Authors:  Chang-Ai Xu; Andrew Z Feng; Charan K Ramineni; Matthew R Wallace; Elizabeth K Culyba; Kevin P Guay; Kinjal Mehta; Robert Mabry; Stephen Farrand; Jin Xu; Jianwen Feng
Journal:  MAbs       Date:  2019-07-11       Impact factor: 5.857

8.  Individuals with IgG4-related disease do not have an increased frequency of the K409 variant of IgG4 that compromises Fab-arm exchange.

Authors:  Maimuna Ahmad; Vinay S Mahajan; Hamid Mattoo; John H Stone; Shiv Pillai
Journal:  J Rheumatol       Date:  2014-01       Impact factor: 4.666

Review 9.  IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.

Authors:  Maartje G Huijbers; Jaap J Plomp; Silvère M van der Maarel; Jan J Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

10.  Estimation of polyclonal IgG4 hybrids in normal human serum.

Authors:  Elizabeth Young; Emma Lock; Douglas G Ward; Alexander Cook; Stephen Harding; Gregg L F Wallis
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.